10 20 30 40 50 60 70 80 3FLN - Header ----|----|----|----|----|----|----|----|----|----|----|----|----|----|----|----| Asymmetric UnitHEADER SIGNALING PROTEIN, TRANSFERASE 19-DEC-08 3FLN
TITLE P38 KINASE CRYSTAL STRUCTURE IN COMPLEX WITH R1487
COMPND MOL_ID: 1; COMPND 2 MOLECULE: MITOGEN-ACTIVATED PROTEIN KINASE 14; COMPND 3 CHAIN: C; COMPND 4 SYNONYM: MITOGEN-ACTIVATED PROTEIN KINASE P38 ALPHA, MAP COMPND 5 KINASE P38 ALPHA, CYTOKINE SUPPRESSIVE ANTI-INFLAMMATORY COMPND 6 DRUG-BINDING PROTEIN, CSAID-BINDING PROTEIN, CSBP, MAX- COMPND 7 INTERACTING PROTEIN 2, MAP KINASE MXI2, SAPK2A; COMPND 8 EC: 2.7.11.24; COMPND 9 ENGINEERED: YES
SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: CSBP, CSBP1, CSBP2, CSPB1, MAPK14, MXI2; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562
KEYWDS P38; MAP KINASE; SERINE/THREONINE KINASE, ALTERNATIVE KEYWDS 2 SPLICING, ATP-BINDING, CYTOPLASM, KINASE, NUCLEOTIDE- KEYWDS 3 BINDING, NUCLEUS, PHOSPHOPROTEIN, POLYMORPHISM, KEYWDS 4 SERINE/THREONINE-PROTEIN KINASE, TRANSFERASE, SIGNALING KEYWDS 5 PROTEIN
EXPDTA X-RAY DIFFRACTION
AUTHOR A.KUGLSTATTER,M.KNAPP
REVDAT 1 22-DEC-09 3FLN 0
JRNL AUTH M.SOTH,A.KUGLSTATTER,D.GOLDSTEIN JRNL TITL THE DISCOVERY OF PAMAPIMOD, R1503 AND R1487 AS JRNL TITL 2 ORALLY BIOAVAILABLE AND HIGHLY SELECTIVE INHIBITORS JRNL TITL 3 OF P38 MAP KINASE JRNL REF TO BE PUBLISHED JRNL REFN
REMARK 1
REMARK 2 REMARK 2 RESOLUTION. 1.90 ANGSTROMS.
REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0005 REMARK 3 AUTHORS : MURSHUDOV,VAGIN,DODSON REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.90 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 20.30 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 97.8 REMARK 3 NUMBER OF REFLECTIONS : 36735 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.211 REMARK 3 R VALUE (WORKING SET) : 0.210 REMARK 3 FREE R VALUE : 0.234 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1942 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.90 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.95 REMARK 3 REFLECTION IN BIN (WORKING SET) : 2684 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 98.67 REMARK 3 BIN R VALUE (WORKING SET) : 0.2600 REMARK 3 BIN FREE R VALUE SET COUNT : 141 REMARK 3 BIN FREE R VALUE : 0.3050 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2766 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 28 REMARK 3 SOLVENT ATOMS : 359 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 28.04 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.00000 REMARK 3 B22 (A**2) : -0.30000 REMARK 3 B33 (A**2) : 0.30000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.148 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.134 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.090 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 2.993 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.944 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.937 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2860 ; 0.007 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 3884 ; 0.967 ; 1.975 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 340 ; 5.250 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 134 ;37.165 ;24.179 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 492 ;13.266 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 17 ;16.313 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 433 ; 0.067 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2156 ; 0.003 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 1301 ; 0.184 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 1975 ; 0.300 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 269 ; 0.102 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 40 ; 0.120 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 18 ; 0.074 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1765 ; 0.544 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2780 ; 0.956 ; 2.000 REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1288 ; 1.005 ; 3.000 REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1104 ; 1.635 ; 4.500 REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL
REMARK 4 REMARK 4 3FLN COMPLIES WITH FORMAT V. 3.20, 01-DEC-08
REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 29-DEC-08. REMARK 100 THE RCSB ID CODE IS RCSB050742.
REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.6 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ALS REMARK 200 BEAMLINE : 5.0.2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : NULL REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 39552 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.900 REMARK 200 RESOLUTION RANGE LOW (A) : 20.300 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.8 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.90 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.97 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.8 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL
REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 57.08 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.87 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 50 MM HEPES PH 7.6, 50 MM CACL2, REMARK 280 17% PEG 3350, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 290K
REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 22.84950 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 62.39650 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 42.94000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 62.39650 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 22.84950 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 42.94000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL
REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA.
REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET C -11 REMARK 465 ARG C -10 REMARK 465 GLY C -9 REMARK 465 SER C -8 REMARK 465 HIS C -7 REMARK 465 HIS C -6 REMARK 465 HIS C -5 REMARK 465 HIS C -4 REMARK 465 HIS C -3 REMARK 465 HIS C -2 REMARK 465 GLY C -1 REMARK 465 SER C 0 REMARK 465 MET C 1 REMARK 465 SER C 2 REMARK 465 CYS C 119 REMARK 465 GLN C 120 REMARK 465 LYS C 121 REMARK 465 LEU C 122 REMARK 465 ALA C 172 REMARK 465 ARG C 173 REMARK 465 HIS C 174 REMARK 465 LEU C 353 REMARK 465 ASP C 354 REMARK 465 GLN C 355 REMARK 465 GLU C 356 REMARK 465 GLU C 357 REMARK 465 MET C 358 REMARK 465 GLU C 359 REMARK 465 SER C 360
REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LEU C 13 -78.36 -126.75 REMARK 500 ASN C 14 55.57 -94.92 REMARK 500 LYS C 15 19.07 56.95 REMARK 500 ILE C 116 -46.33 -139.61 REMARK 500 ARG C 149 -18.44 81.97 REMARK 500 ASP C 150 42.83 -143.49 REMARK 500 PHE C 274 64.73 -108.01 REMARK 500 LEU C 289 56.24 -93.81 REMARK 500 REMARK 500 REMARK: NULL
REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH C 589 DISTANCE = 5.14 ANGSTROMS REMARK 525 HOH C 630 DISTANCE = 5.05 ANGSTROMS REMARK 525 HOH C 649 DISTANCE = 5.53 ANGSTROMS REMARK 525 HOH C 678 DISTANCE = 6.17 ANGSTROMS REMARK 525 HOH C 707 DISTANCE = 5.22 ANGSTROMS
REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 3FN C 361
REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3FLQ RELATED DB: PDB REMARK 900 RELATED ID: 3FLS RELATED DB: PDB REMARK 900 RELATED ID: 3FLW RELATED DB: PDB REMARK 900 RELATED ID: 3FLY RELATED DB: PDB REMARK 900 RELATED ID: 3FLZ RELATED DB: PDB REMARK 900 RELATED ID: 3FMH RELATED DB: PDB REMARK 900 RELATED ID: 3FMJ RELATED DB: PDB REMARK 900 RELATED ID: 3FMK RELATED DB: PDB
DBREF 3FLN C 1 360 UNP Q16539 MK14_HUMAN 1 360
SEQADV 3FLN MET C -11 UNP Q16539 EXPRESSION TAG SEQADV 3FLN ARG C -10 UNP Q16539 EXPRESSION TAG SEQADV 3FLN GLY C -9 UNP Q16539 EXPRESSION TAG SEQADV 3FLN SER C -8 UNP Q16539 EXPRESSION TAG SEQADV 3FLN HIS C -7 UNP Q16539 EXPRESSION TAG SEQADV 3FLN HIS C -6 UNP Q16539 EXPRESSION TAG SEQADV 3FLN HIS C -5 UNP Q16539 EXPRESSION TAG SEQADV 3FLN HIS C -4 UNP Q16539 EXPRESSION TAG SEQADV 3FLN HIS C -3 UNP Q16539 EXPRESSION TAG SEQADV 3FLN HIS C -2 UNP Q16539 EXPRESSION TAG SEQADV 3FLN GLY C -1 UNP Q16539 EXPRESSION TAG SEQADV 3FLN SER C 0 UNP Q16539 EXPRESSION TAG SEQADV 3FLN LYS C 57 UNP Q16539 ARG 57 ENGINEERED
SEQRES 1 C 372 MET ARG GLY SER HIS HIS HIS HIS HIS HIS GLY SER MET SEQRES 2 C 372 SER GLN GLU ARG PRO THR PHE TYR ARG GLN GLU LEU ASN SEQRES 3 C 372 LYS THR ILE TRP GLU VAL PRO GLU ARG TYR GLN ASN LEU SEQRES 4 C 372 SER PRO VAL GLY SER GLY ALA TYR GLY SER VAL CYS ALA SEQRES 5 C 372 ALA PHE ASP THR LYS THR GLY LEU ARG VAL ALA VAL LYS SEQRES 6 C 372 LYS LEU SER LYS PRO PHE GLN SER ILE ILE HIS ALA LYS SEQRES 7 C 372 ARG THR TYR ARG GLU LEU ARG LEU LEU LYS HIS MET LYS SEQRES 8 C 372 HIS GLU ASN VAL ILE GLY LEU LEU ASP VAL PHE THR PRO SEQRES 9 C 372 ALA ARG SER LEU GLU GLU PHE ASN ASP VAL TYR LEU VAL SEQRES 10 C 372 THR HIS LEU MET GLY ALA ASP LEU ASN ASN ILE VAL LYS SEQRES 11 C 372 CYS GLN LYS LEU THR ASP ASP HIS VAL GLN PHE LEU ILE SEQRES 12 C 372 TYR GLN ILE LEU ARG GLY LEU LYS TYR ILE HIS SER ALA SEQRES 13 C 372 ASP ILE ILE HIS ARG ASP LEU LYS PRO SER ASN LEU ALA SEQRES 14 C 372 VAL ASN GLU ASP CYS GLU LEU LYS ILE LEU ASP PHE GLY SEQRES 15 C 372 LEU ALA ARG HIS THR ASP ASP GLU MET THR GLY TYR VAL SEQRES 16 C 372 ALA THR ARG TRP TYR ARG ALA PRO GLU ILE MET LEU ASN SEQRES 17 C 372 TRP MET HIS TYR ASN GLN THR VAL ASP ILE TRP SER VAL SEQRES 18 C 372 GLY CYS ILE MET ALA GLU LEU LEU THR GLY ARG THR LEU SEQRES 19 C 372 PHE PRO GLY THR ASP HIS ILE ASP GLN LEU LYS LEU ILE SEQRES 20 C 372 LEU ARG LEU VAL GLY THR PRO GLY ALA GLU LEU LEU LYS SEQRES 21 C 372 LYS ILE SER SER GLU SER ALA ARG ASN TYR ILE GLN SER SEQRES 22 C 372 LEU THR GLN MET PRO LYS MET ASN PHE ALA ASN VAL PHE SEQRES 23 C 372 ILE GLY ALA ASN PRO LEU ALA VAL ASP LEU LEU GLU LYS SEQRES 24 C 372 MET LEU VAL LEU ASP SER ASP LYS ARG ILE THR ALA ALA SEQRES 25 C 372 GLN ALA LEU ALA HIS ALA TYR PHE ALA GLN TYR HIS ASP SEQRES 26 C 372 PRO ASP ASP GLU PRO VAL ALA ASP PRO TYR ASP GLN SER SEQRES 27 C 372 PHE GLU SER ARG ASP LEU LEU ILE ASP GLU TRP LYS SER SEQRES 28 C 372 LEU THR TYR ASP GLU VAL ILE SER PHE VAL PRO PRO PRO SEQRES 29 C 372 LEU ASP GLN GLU GLU MET GLU SER
HET 3FN C 361 28
HETNAM 3FN 6-(2,4-DIFLUOROPHENOXY)-8-METHYL-2-(TETRAHYDRO-2H- HETNAM 2 3FN PYRAN-4-YLAMINO)PYRIDO[2,3-D]PYRIMIDIN-7(8H)-ONE
FORMUL 2 3FN C19 H18 F2 N4 O3 FORMUL 3 HOH *359(H2 O)
HELIX 1 1 SER C 61 MET C 78 1 18 HELIX 2 2 SER C 95 PHE C 99 5 5 HELIX 3 3 ASN C 114 VAL C 117 5 4 HELIX 4 4 THR C 123 ALA C 144 1 22 HELIX 5 5 LYS C 152 SER C 154 5 3 HELIX 6 6 ASP C 176 THR C 180 5 5 HELIX 7 7 VAL C 183 TYR C 188 1 6 HELIX 8 8 ALA C 190 LEU C 195 1 6 HELIX 9 9 THR C 203 GLY C 219 1 17 HELIX 10 10 ASP C 227 GLY C 240 1 14 HELIX 11 11 GLY C 243 ILE C 250 1 8 HELIX 12 12 SER C 252 GLN C 260 1 9 HELIX 13 13 ASN C 269 PHE C 274 1 6 HELIX 14 14 ASN C 278 LEU C 289 1 12 HELIX 15 15 ASP C 292 ARG C 296 5 5 HELIX 16 16 THR C 298 ALA C 304 1 7 HELIX 17 17 HIS C 305 ALA C 309 5 5 HELIX 18 18 ASP C 313 GLU C 317 5 5 HELIX 19 19 GLN C 325 ARG C 330 5 6 HELIX 20 20 LEU C 333 PHE C 348 1 16
SHEET 1 A 2 PHE C 8 GLU C 12 0 SHEET 2 A 2 ILE C 17 PRO C 21 -1 O TRP C 18 N GLN C 11 SHEET 1 B 5 TYR C 24 GLY C 33 0 SHEET 2 B 5 GLY C 36 ASP C 43 -1 O ALA C 40 N SER C 28 SHEET 3 B 5 LEU C 48 LEU C 55 -1 O VAL C 52 N CYS C 39 SHEET 4 B 5 TYR C 103 HIS C 107 -1 O LEU C 104 N LYS C 53 SHEET 5 B 5 ASP C 88 PHE C 90 -1 N ASP C 88 O VAL C 105 SHEET 1 C 3 ALA C 111 ASP C 112 0 SHEET 2 C 3 LEU C 156 VAL C 158 -1 O VAL C 158 N ALA C 111 SHEET 3 C 3 LEU C 164 ILE C 166 -1 O LYS C 165 N ALA C 157
SITE 1 AC1 15 GLY C 33 VAL C 38 ALA C 51 LYS C 53 SITE 2 AC1 15 LEU C 86 LEU C 104 VAL C 105 THR C 106 SITE 3 AC1 15 HIS C 107 MET C 109 ALA C 111 ASP C 112 SITE 4 AC1 15 ASN C 115 HOH C 381 HOH C 464
CRYST1 45.699 85.880 124.793 90.00 90.00 90.00 P 21 21 21 4
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.021882 0.000000 0.000000 0.00000
SCALE2 0.000000 0.011644 0.000000 0.00000
SCALE3 0.000000 0.000000 0.008013 0.00000